Kazia Therapeutics Issues 95,110 ADSs, Raising ~$0.7 Million

summarizeSummary

Kazia Therapeutics filed a prospectus supplement detailing the issuance of 95,110 American Depositary Shares, representing a capital raise of approximately $0.7 million, which is dilutive to existing shareholders.

check_boxKey Events

• ADS Issuance

  Kazia Therapeutics issued 95,110 American Depositary Shares, representing 47,555,000 ordinary shares, as an update to its existing prospectus.

• Capital Raised

  This issuance is valued at approximately $0.7 million, based on the March 30, 2026 closing price of $7.31 per ADS.

• Dilutive Impact

  The issuance of these new shares will result in dilution for current shareholders.

• Board Changes Noted

  The filing incorporates details of the Chairman's resignation and board reduction, which were previously reported on March 31, 2026.

auto_awesomeAnalysis

This prospectus supplement details the issuance of 95,110 American Depositary Shares (ADSs), representing a capital raise of approximately $0.7 million. This transaction, while providing additional capital, is dilutive to existing shareholders. The filing also incorporates information from a previously reported 6-K on March 31, 2026, regarding the resignation of Chairman Bryce Carmine and a reduction in board size, which was already publicly disclosed.